Jazz Pharmaceuticals
JAZZ
JAZZ
505 hedge funds and large institutions have $7.27B invested in Jazz Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 170 increasing their positions, 169 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 474 → 505 (+31)
4.24% more ownership
Funds ownership: 93.42% → 97.67% (+4.2%)
1% more repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 169
Holders
505
Holding in Top 10
10
Calls
$17M
Puts
$7.36M
Top Buyers
| 1 | +$62.5M | |
| 2 | +$59.7M | |
| 3 | +$39.5M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$38.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$38.9M |
Top Sellers
| 1 | -$67.4M | |
| 2 | -$56.6M | |
| 3 | -$27.1M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$24.8M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$24.2M |